# Biotech Daily Digest ‚Äî 2026-02-26

**31 items from 4 sources**

## Summary by Source

- Eli Lilly Press Releases: 1 item
- Endpoints News: 5 items
- Fierce Biotech: 4 items
- arXiv q-bio: 21 items


## Eli Lilly Press Releases

- **[Lilly's oral GLP-1, orforglipron, delivered superior blood sugar control and weight loss compared to oral semaglutide in head-to-head type 2 diabetes trial published in The Lancet](https://investor.lilly.com/news-releases/news-release-details/lillys-oral-glp-1-orforglipron-delivered-superior-blood-sugar)**  
  _Thu, 26 Feb 2026 06:30:00 -0500_  
  For the primary endpoint, orforglipron 36 mg lowered A1C by 2.2% vs. 1.4% with oral semaglutide 14 mg in ACHIEVE-3 In a key secondary endpoint, participants on orforglipron 36 mg lost 19.7 lbs (9.2%) compared to 11.0 lbs (5.3%) with oral semaglutide 14 mg, representing a 73.6% greater relative


## Endpoints News

- **[Lilly's GLP-1 pill beats Novo‚Äôs in diabetes trial, has more side effects](https://endpoints.news/lillys-glp-1-pill-beats-novos-in-diabetes-trial-has-more-side-effects/)**  
  _Thu, 26 Feb 2026 11:30:10 +0000_  
  The second head-to-head Phase 3 trial in a week between dueling metabolic drugs from Eli Lilly and Novo Nordisk was reported Thursday. Once again, the data went Lilly‚Äôs way.

 The latest data came from a ...

- **[Gilead, Merck plan to debut new daily HIV pills](https://endpoints.news/gilead-merck-plan-to-debut-new-daily-hiv-pills/)**  
  _Wed, 25 Feb 2026 21:01:54 +0000_  
  Gilead and Merck together are developing what could be the first weekly HIV pill, but they are also each making an individual push for new daily drugs.

 The two companies separately reported findings Wednesday from ...

- **[Accent axes a cancer study; Werewolf considers its options](https://endpoints.news/accent-axes-a-cancer-study-werewolf-considers-its-options/)**  
  _Wed, 25 Feb 2026 15:38:29 +0000_  
  Plus, news about Beam Therapeutics, Pfizer‚Äôs Braftovi regimen, Lonestar Medicines, the NOFLU vaccine consortium and Zura Bio:

 ü™ì Accent axes DHX9 inhibitor study: The biotech terminated the Phase 1 ...

- **[Alkermes CEO Richard Pops to retire after 35-year tenure](https://endpoints.news/alkermes-ceo-richard-pops-to-retire-after-35-year-tenure/)**  
  _Wed, 25 Feb 2026 15:28:13 +0000_  
  Alkermes‚Äô longtime CEO will step down this summer.

 Richard Pops plans to pass the torch to COO Blair Jackson, Alkermes announced Wednesday, wrapping up a career that spanned seven US presidencies. Pops‚Äô final day will ...

- **[States sue Kennedy over US childhood vaccine overhaul](https://endpoints.news/states-sue-kennedy-over-us-childhood-vaccine-overhaul/)**  
  _Wed, 25 Feb 2026 14:57:13 +0000_  
  HHS Secretary Robert F. Kennedy Jr. faces a second legal challenge related to the overhaul of the childhood vaccine schedule.

 Fifteen states claimed that HHS‚Äô decision to downgrade recommendations for six vaccines ...


## Fierce Biotech

- **[<a href="https://www.fiercebiotech.com/medtech/quantum-surgical-snaps-jjs-neuwave-medical-its-microwave-ablation-technology" hreflang="en">Quantum Surgical snaps up J&amp;J's NeuWave Medical for its microwave ablation technology</a>](https://www.fiercebiotech.com/medtech/quantum-surgical-snaps-jjs-neuwave-medical-its-microwave-ablation-technology)**  
  _Feb 26, 2026 3:36am_  
  Quantum Surgical is looking to become the ‚Äúleader in the interventional radiology industry‚Äù with its buyout of Johnson & Johnson‚Äôs cancer ablation company NeuWave Medical.

- **[<a href="https://www.fiercebiotech.com/biotech/bristol-myers-84b-adc-hits-primary-survival-endpoints-phase-3-breast-cancer-trial" hreflang="en">Bristol Myers' $800M ADC hits primary survival endpoints in phase 3 breast cancer trial</a>](https://www.fiercebiotech.com/biotech/bristol-myers-84b-adc-hits-primary-survival-endpoints-phase-3-breast-cancer-trial)**  
  _Feb 26, 2026 9:09am_  
  A Chinese phase 3 trial of Bristol Myers Squibb‚Äôs antibody-drug conjugate has hit its dual primary survival endpoints, providing further validation of the Big Pharma's $800 million bet on the candidate.

- **[<a href="https://www.fiercebiotech.com/biotech/accent-halts-solid-tumor-trial-over-adverse-events-pivots-other-lead-cancer-program" hreflang="en">Accent halts solid tumor trial over adverse events, pivots to other lead cancer program</a>](https://www.fiercebiotech.com/biotech/accent-halts-solid-tumor-trial-over-adverse-events-pivots-other-lead-cancer-program)**  
  _Feb 26, 2026 5:02am_  
  Accent Therapeutics has halted work on a solid tumor drug due to adverse events in a phase 1/2 study.

- **[<a href="https://www.fiercebiotech.com/biotech/asahi-kasei-accrue-german-aicuris-920-million-rd-portfolio-boost" hreflang="en">Asahi Kasei scoops up Germany's Aicuris for $920M in R&amp;D portfolio boost</a>](https://www.fiercebiotech.com/biotech/asahi-kasei-accrue-german-aicuris-920-million-rd-portfolio-boost)**  
  _Feb 25, 2026 2:36pm_  
  Japanese conglomerate Asahi Kasei is acquiring Aicuris in a $920 million deal that will allow Asahi to add approved and investigational assets designed to treat and protect against viral infections in immunocompromised individuals.


## arXiv q-bio

- **[An information-based model selection criterion for data-driven model discovery](https://arxiv.org/abs/2602.21393)**  
  _Thu, 26 Feb 2026 00:00:00 -0500_  
  arXiv:2602.21393v1 Announce Type: new 
Abstract: Data-driven model discovery (DDMD) algorithms are powerful tools for extracting interpretable symbolic models from data. However, identifying the model that best balances goodness-of-fit and sparsity is often a laborious process requiring user fine-tuning, is prone to o‚Ä¶

- **[Towards Structure-Aware Surrogate Modeling: Explicit Region Interaction Improves Knee Contact Stress Prediction](https://arxiv.org/abs/2602.21488)**  
  _Thu, 26 Feb 2026 00:00:00 -0500_  
  arXiv:2602.21488v1 Announce Type: new 
Abstract: Knee contact-stress hotspots are closely linked to meniscal/cartilage injury risk. Still, high-fidelity subject-specific FEA is too computationally expensive for large-cohort, multi-condition, near-real-time use. Existing MeshGraphNet-style surrogates mainly rely on sta‚Ä¶

- **[One Brain, Omni Modalities: Towards Unified Non-Invasive Brain Decoding with Large Language Models](https://arxiv.org/abs/2602.21522)**  
  _Thu, 26 Feb 2026 00:00:00 -0500_  
  arXiv:2602.21522v1 Announce Type: new 
Abstract: Deciphering brain function through non-invasive recordings requires synthesizing complementary high-frequency electromagnetic (EEG/MEG) and low-frequency metabolic (fMRI) signals. However, despite their shared neural origins, extreme discrepancies have traditionally con‚Ä¶

- **[Limits of optimal decoding under synaptic coarse-tuning](https://arxiv.org/abs/2602.21758)**  
  _Thu, 26 Feb 2026 00:00:00 -0500_  
  arXiv:2602.21758v1 Announce Type: new 
Abstract: Sensory information propagates through successive processing stages in the brain, where synaptic weight patterns between stations determine how downstream neurons decode information from upstream populations. Although optimized synaptic connectivity can enhance informat‚Ä¶

- **[Spectral entropy of the discrete Hasimoto effective potential exposes sub-residue geometric transitions in protein secondary structure](https://arxiv.org/abs/2602.21787)**  
  _Thu, 26 Feb 2026 00:00:00 -0500_  
  arXiv:2602.21787v1 Announce Type: new 
Abstract: Characterizing the geometric boundaries of protein secondary structures is fundamental to understanding macromolecular folding. By applying the discrete Hasimoto map to translate backbone geometry into a one-dimensional discrete nonlinear Schr\"{o}dinger potential $V_{\‚Ä¶

- **[Prediction of source nutrients for microorganisms using metabolic networks](https://arxiv.org/abs/2602.21993)**  
  _Thu, 26 Feb 2026 00:00:00 -0500_  
  arXiv:2602.21993v1 Announce Type: new 
Abstract: Metagenomics has lowered the barrier to microbial discovery--enabling the identification of novel microbes without isolation--but cultures remain imperative for the deep study of microbes. Cultivation and isolation of non-model microbes remains a major challenge, despit‚Ä¶

- **[BEDCrypt: Privacy-preserving interval analytics with homomorphic encryption](https://arxiv.org/abs/2602.21994)**  
  _Thu, 26 Feb 2026 00:00:00 -0500_  
  arXiv:2602.21994v1 Announce Type: new 
Abstract: Motivation. Genomic data and derived interval datasets can carry sensitive information, and the analysis itself can reveal an analyst's intent. As genomic workloads are increasingly outsourced to third-party infrastructure, there is a need for privacy-preserving technol‚Ä¶

- **[From female choice to social structure: Modeling harem formation in camelids](https://arxiv.org/abs/2602.22139)**  
  _Thu, 26 Feb 2026 00:00:00 -0500_  
  arXiv:2602.22139v1 Announce Type: new 
Abstract: Herbivorous wild species constantly strive to optimize the trade-off between energy and nutrient intake and predation risk during foraging. This has led to the selection of several evolutionary traits -- such as diet, habitat selection, and behavior -- which are simulta‚Ä¶

- **[Effects of Training Data Quality on Classifier Performance](https://arxiv.org/abs/2602.21462)**  
  _Thu, 26 Feb 2026 00:00:00 -0500_  
  arXiv:2602.21462v1 Announce Type: cross 
Abstract: We describe extensive numerical experiments assessing and quantifying how classifier performance depends on the quality of the training data, a frequently neglected component of the analysis of classifiers.
  More specifically, in the scientific context of metagenomic‚Ä¶

- **[Modeling plant disease spread via high-resolution human mobility networks](https://arxiv.org/abs/2602.21491)**  
  _Thu, 26 Feb 2026 00:00:00 -0500_  
  arXiv:2602.21491v1 Announce Type: cross 
Abstract: Human mobility plays a crucial role in the spread of human diseases, but is rarely quantified in plant disease epidemics. To address this gap, we integrate a unique, high-resolution network of human movements in New Zealand with a metapopulation model to mechanistical‚Ä¶

- **[Extending Sequence Length is Not All You Need: Effective Integration of Multimodal Signals for Gene Expression Prediction](https://arxiv.org/abs/2602.21550)**  
  _Thu, 26 Feb 2026 00:00:00 -0500_  
  arXiv:2602.21550v1 Announce Type: cross 
Abstract: Gene expression prediction, which predicts mRNA expression levels from DNA sequences, presents significant challenges. Previous works often focus on extending input sequence length to locate distal enhancers, which may influence target genes from hundreds of kilobases‚Ä¶

- **[Asymmetry Demystified: Strict CLFs and Feedbacks for Predator-Prey Interconnections](https://arxiv.org/abs/2602.21594)**  
  _Thu, 26 Feb 2026 00:00:00 -0500_  
  arXiv:2602.21594v1 Announce Type: cross 
Abstract: The difficulty with control of population dynamics, besides the states being positive and the control having to also be positive, is the extreme difference in the dynamics near extinction and at overpopulated states. As hard as global stabilization is, even harder is‚Ä¶

- **[Multimodal Survival Modeling and Fairness-Aware Clinical Machine Learning for 5-Year Breast Cancer Risk Prediction](https://arxiv.org/abs/2602.21648)**  
  _Thu, 26 Feb 2026 00:00:00 -0500_  
  arXiv:2602.21648v1 Announce Type: cross 
Abstract: Clinical risk prediction models often underperform in real-world settings due to poor calibration, limited transportability, and subgroup disparities. These challenges are amplified in high-dimensional multimodal cancer datasets characterized by complex feature intera‚Ä¶

- **[Universal Persistent Brownian Motions in Confluent Tissues](https://arxiv.org/abs/2602.21922)**  
  _Thu, 26 Feb 2026 00:00:00 -0500_  
  arXiv:2602.21922v1 Announce Type: cross 
Abstract: Biological tissues are active materials whose non-equilibrium dynamics emerge from distinct cellular force-generating mechanisms. Using a two-dimensional active foam model, we compare the effects of traction forces and junctional tension fluctuations on confluent tiss‚Ä¶

- **[From quantitative modeling of fluorescence experiments on biomolecules to the prediction of spectroscopic dye properties](https://arxiv.org/abs/2602.21931)**  
  _Thu, 26 Feb 2026 00:00:00 -0500_  
  arXiv:2602.21931v1 Announce Type: cross 
Abstract: Fluorescence spectroscopy and modeling provide powerful means to characterize biomacromolecular structures, dynamics, and interactions. F\"orster resonance energy transfer serves as a key technique for this due to its nanometer-scale distance sensitivity. Quantitative‚Ä¶

- **[Confidence is detection-like in high-dimensional spaces](https://arxiv.org/abs/2410.18933)**  
  _Thu, 26 Feb 2026 00:00:00 -0500_  
  arXiv:2410.18933v3 Announce Type: replace 
Abstract: Confidence estimates are often "detection-like" - driven by positive evidence in favour of a decision. This empirical observation has been interpreted as showing human metacognition is limited by biases or heuristics. Here we show that Bayesian confidence estimates‚Ä¶

- **[Multi-timescale synaptic plasticity on analog neuromorphic hardware](https://arxiv.org/abs/2412.02515)**  
  _Thu, 26 Feb 2026 00:00:00 -0500_  
  arXiv:2412.02515v2 Announce Type: replace 
Abstract: As numerical simulations grow in complexity, their demands on computing time and energy increase. Accelerators for numerical computation offer significant efficiency gains in many computationally-intensive scientific fields, but their use in simulating spiking neura‚Ä¶

- **[Dynamics of Two Species with Density-Dependent Interactions in a Mutualistic Context](https://arxiv.org/abs/2509.06062)**  
  _Thu, 26 Feb 2026 00:00:00 -0500_  
  arXiv:2509.06062v2 Announce Type: replace 
Abstract: Mutualistic interactions, where individuals from different species can benefit from each other, are widespread across ecosystems. This study develops a general deterministic model of mutualism involving two populations, assuming that mutualism may involve both costs‚Ä¶

- **[From the Hallmarks of Cancer to the Survival System: A Paradigmatic Reconstruction of Oncological Theory through the Existential Crisis-Driven Survival (ECDS) Framework](https://arxiv.org/abs/2601.09767)**  
  _Thu, 26 Feb 2026 00:00:00 -0500_  
  arXiv:2601.09767v2 Announce Type: replace 
Abstract: Malignant tumors exhibit complex pathogenesis, yet classical oncological theories remain fragmented, failing to provide a unifying framework to address this complexity. This gap limits the utility and translational potential of the prevailing "confront-and-eradicate‚Ä¶

- **[Local stabilizability implies global controllability in catalytic reaction systems](https://arxiv.org/abs/2505.06834)**  
  _Thu, 26 Feb 2026 00:00:00 -0500_  
  arXiv:2505.06834v3 Announce Type: replace-cross 
Abstract: Controlling complex reaction networks is a fundamental challenge in the fields of physics, biology, and systems engineering. Here, we prove a general principle for catalytic reaction systems with kinetics where the reaction order and the stoichiometric coeffic‚Ä¶

- **[Quantum enhanced ensemble GANs for anomaly detection in continuous biomanufacturing](https://arxiv.org/abs/2508.21438)**  
  _Thu, 26 Feb 2026 00:00:00 -0500_  
  arXiv:2508.21438v2 Announce Type: replace-cross 
Abstract: The development of continuous biomanufacturing processes requires robust and early anomaly detection, since even minor deviations can compromise yield and stability, leading to disruptions in scheduling, reduced weekly production, and diminished economic perfo‚Ä¶
